throbber

`
`Nos. 19-1434, 19-1452, 19-1458
`
`In the Supreme Court of the United States
`____________
`United States of America,
`
`v.
`Arthrex, Inc., et al.,
`
`Petitioner,
`
`Respondents.
`
`____________
`On Writ of Certiorari to the United States Court
`of Appeals for the Federal Circuit
`____________
`BRIEF AMICUS CURIAE OF TIVO
`CORPORATION IN SUPPORT OF
`RESPONDENT ARTHREX
`____________
`
`MICHAEL E. JOFFRE
` Counsel of Record
`JASON D. EISENBERG
`WILLIAM H. MILLIKEN
`STERNE, KESSLER, GOLDSTEIN & FOX, PLLC
`1100 New York Avenue, N.W.
`Washington, D.C. 20005
`(202) 772-8856
`mjoffre@sternekessler.com
`Counsel for Amicus Curiae TiVo Corporation
`December 30, 2020
`
`(Additional Captions Listed on Inside Cover)
`
`

`

`
`
`____________
`
`Smith & Nephew, Inc., et al.,
`Petitioners,
`
`v.
`
`Arthrex, Inc., et al.,
`
`____________
`
`Arthrex, Inc.,
`
`Respondents.
`
`Petitioner,
`
`v.
`Smith & Nephew, Inc., et al.,
`Respondents.
`
`____________
`
`
`
`
`
`
`
`

`

`
`
`TABLE OF CONTENTS
`
`TABLE OF AUTHORITIES ..................................... iii
`INTEREST OF AMICUS CURIAE ........................... 1
`INTRODUCTION AND SUMMARY OF
`ARGUMENT ......................................................... 3
`ARGUMENT .............................................................. 6
`I. The inter partes review regime has failed to
`provide a satisfactory forum for adjudicating
`patent rights. ........................................................ 6
`A. Patent infringers frequently abuse the inter
`partes review process to conduct multiple
`attacks on the validity of patents, thereby
`depriving patent owners of quiet title over
`their inventions. .............................................. 6
`B. The Board’s extraordinarily high claim-
`cancellation rates confirm that the inter
`partes review process is not a neutral
`alternative to adjudication of patent rights in
`federal court. .................................................. 13
`1. Contrary to the suggestion of several
`amici, the Board’s claim-cancellation rates
`are much higher than those of district
`courts. ....................................................... 13
`2. The high affirmance rate of Board
`decisions reflects the forgiving standard of
`review on appeal—not necessarily accuracy
`on the part of the Board. .......................... 15
`
`
`
`
`
`

`

`ii
`
`II. The Federal Circuit’s removal of administrative
`patent judges’ tenure protections exacerbates the
`problems inherent in the inter partes review
`regime. ................................................................. 17
`A. The court of appeals’ remedy undermines the
`independence of administrative patent judges,
`contravening longstanding principles of
`administrative adjudication. ......................... 18
`B. Subjecting administrative patent judges to at-
`will removal magnifies problematic structural
`biases already present in the inter partes
`review process. ............................................... 20
`III.The task of remedying the Appointments Clause
`violation properly belongs with Congress, not the
`courts. .................................................................. 26
`CONCLUSION ......................................................... 27
`
`
`
`
`
`
`
`

`

`iii
`
`TABLE OF AUTHORITIES
`
` Page(s)
`
`Cases
`
`Aetna Life Ins. Co. v. Lavoie,
`475 U.S. 813 (1986) ........................................... 21
`
`Brown v. Vance,
`637 F.2d 272 (5th Cir. 1981) ....................... 24, 25
`
`Butz v. Economou,
`438 U.S. 478 (1978) ........................................... 19
`
`Cain v. White,
`937 F.3d 446 (5th Cir. 2019) ............................. 21
`
`Certain Digital Video Receivers and
`Related Hardware and Software
`Components, Initial Determination,
`Inv. No. 337-TA-1103
`(U.S.I.T.C. June 27, 2019) .................................. 7
`
`Chrimar Sys., Inc. v. ALE USA Inc.,
`785 F. App’x 854 (Fed. Cir. 2019) ..................... 11
`
`Comcast Cable Commc’ns, LLC v. Rovi
`Guides, Inc.,
`No. IPR2019-00231, Paper 44
`(P.T.A.B. May 8, 2020) ........................................ 8
`
`
`
`

`

`iv
`
`Comcast Cable Commc’ns, LLC v. Rovi
`Guides, Inc.,
`No. IPR2019-00239, Paper 50
`(P.T.A.B. June 30, 2020) ..................................... 8
`
`Cuozzo Speed Techs., LLC v. Lee,
`136 S. Ct. 2131 (2016) ....................................... 14
`
`Dickinson v. Zurko,
`527 U.S. 150 (1999) ........................................... 15
`
`ePlus, Inc. v. Lawson Software, Inc.,
`760 F.3d 1350 (Fed. Cir. 2014) ................... 10, 11
`
`ePlus, Inc. v. Lawson Software, Inc.,
`790 F.3d 1307 (Fed. Cir. 2015) ......................... 12
`
`Ethicon Endo-Surgery v. Covidien LP,
`812 F.3d 1023 (Fed. Cir. 2016) ......................... 23
`
`Free Enter. Fund v. Pub. Co. Accounting
`Oversight Bd.,
`561 U.S. 477 (2010) ........................................... 19
`
`Fresenius USA, Inc. v. Baxter Int’l, Inc.,
`721 F.3d 1330 (Fed. Cir. 2013) ................... 10, 11
`
`Fresenius USA, Inc. v. Baxter Int’l, Inc.,
`733 F.3d 1369 (Fed. Cir. 2013) ......................... 12
`
`Henkel Corp. v. Procter & Gamble Co.,
`560 F.3d 1286 (Fed. Cir. 2009) ......................... 15
`
`Hologic, Inc. v. Minerva Surgical, Inc.,
`957 F.3d 1256 (Fed. Cir. 2020) ......................... 11
`
`
`
`

`

`v
`
`Merck & Cie v. Gnosis S.P.A.,
`820 F.3d 432 (Fed. Cir. 2016) ........................... 16
`
`Ramspeck v. Fed. Trial Exam’rs
`Conference,
`345 U.S. 128 (1953) ............................... 18, 19, 20
`
`Rates Tech., Inc. v. Mediatrix Telecom, Inc.,
`688 F.3d 742 (Fed. Cir. 2012) ........................... 17
`
`SHFL Entm’t, Inc. v. DigiDeal Corp.,
`729 F. App’x 931 (Fed. Cir. 2018) ..................... 11
`
`Sung v. McGrath,
`339 U.S. 33 (1950) ............................................. 19
`
`Target Training Int’l, Ltd. v. Extended Disc
`N. Am., Inc.,
`645 F. App’x 1018 (Fed. Cir. 2016) ................... 11
`
`Tumey v. Ohio,
`273 U.S. 510 (1927) ........................................... 25
`
`Statutes
`
`5 U.S.C. § 7521 ................................................. 18, 19
`
`5 U.S.C. § 7521(a) ................................................... 18
`
`
`
`

`

`vi
`
`Other Authorities
`
`Brian Matsui, No Argument, No Opinion—
`a Quick Look at Unargued Rule 36
`Decisions During the Pandemic (Dec. 11,
`2020), available at
`https://www.jdsupra.com/legalnews/no-
`argument-no-opinion-a-quick-look-at-
`40840/ ................................................................ 16
`
`Chad M. Oldfather, Writing, Cognition, and
`the Nature of Judicial Functions,
`96 GEO. L.J. 1283 (2008) ................................... 17
`
`Clark A. Jablon, Is the Sky Falling in the
`US Patent Industry? (May/June 2020),
`available at
`https://onlinelibrary.wiley.com/doi/epdf/1
`0.1002 /msid.111 ................................................. 3
`
`H.R. Rep. No. 112-98, pt. 1 (2011) ........................... 8
`
`John R. Allison et al., Understanding the
`Realities of Modern Patent Litigation,
`92 TEX. L. REV. 1769 (2014) .............................. 14
`
`Josh Malone, Assessing PTAB Invalidity
`Rates, available at
`https://usinventor.org/assessing-ptab-
`invalidity-rates/ (Oct. 22, 2020) ....................... 14
`
`
`
`

`

`vii
`
`Matteo Sabatini, PTAB Challenges and
`Innovation: A Probabilistic Approach,
`SSRN 3668216 (2020), available at
`https://papers.ssrn.com/
`sol3/papers.cfm?abstract_id=3668216 ............... 9
`
`Paul Gugliuzza, (In)valid Patents,
`92 NOTRE DAME L. REV. 271 (2016) .................. 12
`
`Paul Hayes & Gene Quinn, A Note to
`SCOTUS on Arthrex, Judicial
`Independence, Ethics and Expanded
`Panels at the PTAB, IP Watchdog (Aug.
`4, 2020) ................................................................ 3
`
`Rebecca Lindhorst, Because I Said So: The
`Federal Circuit, the PTAB, and the
`Problem with Rule 36 Affirmances, 69
`CASE W. RES. L. REV. 247 (2018) ...................... 16
`
`Restatement (Second) of Judgments § 13. ............ 12
`
`
`
`
`
`

`

`1
`
`INTEREST OF AMICUS CURIAE 1
`
`TiVo Corporation is a global leader in making
`entertainment content easy for consumers to find,
`watch, and enjoy. TiVo produces and distributes
`products that allow users to discover what to watch,
`delivering a personalized selection of shows from
`hundreds of live TV channels and digital content
`providers (including Netflix, Hulu, and YouTube,
`among others). TiVo’s products use machine learning
`to give consumers content recommendations across
`online video, television programming, movies, and
`music entertainment in a unified experience.
`TiVo’s products and innovations are protected by
`thousands of patents that cover many aspects of
`TiVo’s proprietary technology, including content
`discovery, digital video recording (DVR), multi-screen
`viewing, mobile
`device
`video
`experiences,
`entertainment personalization, voice
`interaction,
`data analytics, and more. These innovations and the
`products that practice them have been enormously
`expensive to develop. TiVo’s business thus depends on
`a strong and stable U.S. patent system. Without the
`promise of effective and reliable patent rights, TiVo
`could not make the investments necessary to continue
`developing its path-breaking innovations.
`
`
`1 All parties have consented to the filing of this brief. No
`counsel for a party authored any part of this brief, and no such
`counsel or party made a monetary contribution intended to fund
`the preparation or submission of this brief. No person other than
`amicus curiae, its members, or its counsel made a monetary
`contribution to the brief’s preparation or submission.
`
`
`

`

`2
`
`The Federal Circuit correctly concluded that the
`inter partes review regime created by Congress was
`unconstitutional. But the remedy adopted by the
`court of appeals—the severance and invalidation of
`administrative patent judges’ tenure protections—
`has not fixed the system’s problems. On the contrary,
`it has merely magnified serious flaws that already
`infect the inter partes review process. This regime has
`weakened patent protection and reduced incentives to
`innovate in the United States, to the detriment of
`companies like TiVo and the consumers of its
`products. TiVo submits this amicus brief to describe
`some of the problems with the inter partes review
`system and to explain why the Federal Circuit’s
`misguided remedy has made those problems worse.
`
`
`
`
`
`

`

`3
`
`INTRODUCTION AND
`SUMMARY OF ARGUMENT
`
`the
`concern
`presented
`questions
`The
`constitutionality of the Patent Trial and Appeal
`Board. The Board hears and decides, among other
`proceedings, inter partes reviews—an adversarial
`system of post-grant patent review that Congress
`established in 2012 as part of the America Invents
`Act. Under the inter partes review regime, the
`administrative patent judges who comprise the Board
`render final decisions concerning the validity of
`issued patents. Those decisions are not reviewable by
`any higher
`executive-branch
`official. Thus,
`administrative
`patent
`judges—without
`any
`substantive oversight by anyone else in the executive
`branch—can and do invalidate patents, thereby
`depriving patent owners of vested and valuable
`property rights. The establishment of the inter partes
`review system, moreover, has led to a significant
`increase in the invalidation rate of issued patents.2 In
`short, administrative patent judges wield significant
`power, and it is therefore critical to the stability and
`reliability of
`the U.S. patent
`system
`that
`
`
`2 See, e.g., Clark A. Jablon, Is the Sky Falling in the US
`Patent Industry?, informationdisplay.org (May/June 2020), at
`38, Fig. 12, available at https://onlinelibrary.wiley.com/doi/epdf/
`10.1002/msid.1116. Or, as two commentators colorfully put it,
`“[t]he PTAB has presided over a swath of IP destruction that
`spans more than a generation of innovation.” Paul Hayes & Gene
`Quinn, A Note to SCOTUS on Arthrex, Judicial Independence,
`Ethics and Expanded Panels at the PTAB, IP Watchdog (Aug. 4,
`2020).
`
`
`
`

`

`4
`
`administrative patent judges—and the inter partes
`review
`system as a whole—operate within
`constitutional bounds.
`that
`The court of appeals correctly held
`administrative patent judges’ “last word” capacity
`with respect to patent invalidation renders them
`principal officers who, under the Appointments
`Clause of the Constitution, must be appointed by the
`President with the advice and consent of the Senate.
`Because administrative patent judges are not so
`appointed, the court of appeals correctly found that
`the inter partes review regime established by
`Congress was unconstitutional.
`In attempting to remedy the constitutional
`problem that Congress created, however, the court of
`appeals went astray. The
`court
`invalidated
`administrative patent judges’ tenure protections,
`thereby subjecting them to at-will removal by the
`Secretary of Commerce. This, the court of appeals
`reasoned, rendered administrative patent judges
`inferior officers who may validly be appointed by a
`“Head of Department.”
`As Arthrex explains, the effect of the court of
`appeals’ remedy—subjecting administrative patent
`judges to removal for any reason or no reason at all—
`is demonstrably inconsistent with congressional
`intent. Arthrex Br. 47–56. Even worse, this
`illegitimate severance does not actually fix the
`constitutional problem: even if removable at will,
`administrative patent
`judges remain principal
`officers because they retain the ability to cancel
`previously issued patent claims without review by
`
`
`
`

`

`5
`
`any principal executive officer. See id. at 19–35, 45–
`47.
`On a more practical level, the Federal Circuit’s
`remedy has exacerbated the problems in an already
`flawed regime. Inter partes reviews have proven a
`deeply unsatisfactory process for the adjudication of
`patent rights. They provide patent infringers with an
`opportunity to harass patent owners with repeated
`inter partes review petitions, including in cases where
`the validity of the patent has already been upheld in
`another forum, such as a district court or the
`International Trade Commission. And the infringers
`are all too willing to take advantage of the
`opportunity,
`particularly
`given
`that
`claim-
`cancellation rates
`in
`inter partes reviews are
`considerably higher than those in other fora. TiVo’s
`own experience bears this out: time after time, TiVo
`has successfully defended the validity of its patents in
`the International Trade Commission, only to later
`have the patents invalidated at the hands of the
`Patent Trial and Appeal Board.
`The Federal Circuit’s removal of the Board
`members’ tenure protections only magnifies these
`flaws. For decades—at least since the passage of the
`Administrative Procedure Act—it has been a
`fundamental principle of administrative adjudication
`that agency adjudicators should enjoy protections
`from removal so they can function as independent and
`impartial deciders. The court of appeals disregarded
`that principle and created a significant risk of
`additional unfairness when
`it removed
`those
`protections from administrative patent judges. This
`outcome is particularly problematic given that the
`
`
`

`

`6
`
`system already contains inherent structural biases in
`favor of petitioners and against patent owners. Now
`that administrative patent judges are subject to in
`terrorem supervision, those structural problems come
`into even starker relief.
`TiVo submits this brief to request that this Court
`set aside the court of appeals’ misguided remedy and
`leave the task of repairing the broken inter partes
`review system where it belongs: with Congress.
`
`ARGUMENT
`
`I.
`
`The inter partes review regime has failed to
`provide a satisfactory forum for adjudicating
`patent rights.
`A.
`
`Patent infringers frequently abuse the
`inter partes review process to conduct
`multiple attacks on the validity of
`patents, thereby depriving patent
`owners of quiet title over their
`inventions.
`
`1. TiVo’s experience presents a particularly
`striking example of the abusive purposes for which
`the inter partes review regime can be employed.
`TiVo’s (and its subsidiaries’) patents have been the
`subject of well over one hundred inter partes review
`petitions since November 2016. Thirty-seven patents
`have been challenged—an average of 3.35 petitions
`per patent. In total, only about 5% of the challenged
`claims have survived. Many of these claims had been
`previously upheld against validity challenges by the
`
`
`
`

`

`7
`
`International Trade Commission—a body made up of
`properly appointed principal officers.
`In effect, inter partes reviews have allowed TiVo’s
`competitors to violate its patent rights and then, after
`having been adjudged guilty of that conduct in one
`adjudicatory forum (for example, the ITC), obtain a
`second bite at the apple via one or more inter partes
`review petitions. Even worse, after the
`first
`proceeding has exposed flaws in the infringer’s
`invalidity arguments, the infringer can use those
`proceedings as a roadmap to attempt to fix those flaws
`in the subsequent inter partes review. In effect, the
`first proceeding functions as a practice run for the
`infringer to test out its invalidity case and assess the
`weaknesses in it so it may avoid those weaknesses
`when it challenges the patent before the Board.
`To take one illustrative example, Rovi, a TiVo
`subsidiary, asserted U.S. Patent Nos. 9,369,741 and
`7,779,011 (among other patents) against Comcast
`Cable Communications in Certain Digital Video
`Receivers and Related Hardware and Software
`Components, Inv. No. 337-TA-1103 (U.S.I.T.C.). In
`the course of that proceeding, Comcast tried and
`failed to show that the claims of the ’741 patent were
`invalid in light of a prior-art reference called Sie. See
`Initial Determination on Violation of Section 337 and
`Recommended Determination on Remedy and Bond
`(Public) at 257–60 (June 27, 2019). Comcast also tried
`and failed to show that the claims of the ’011 patent
`were invalid as obvious over two prior-art references
`called Gross and Smith. See id. at 101–13. While the
`ITC
`investigation was ongoing, Comcast
`filed
`multiple inter partes reviews against the ’741 and
`
`
`

`

`8
`
`’011 patents. Using the Commission proceedings as a
`roadmap, Comcast ultimately
`succeeded
`in
`convincing the Board to invalidate those two patents
`based on the very same prior art that the ITC had
`already considered. Specifically, the PTAB concluded
`that the ’741 patent was obvious over Sie, see
`Comcast Cable Commc’ns, LLC v. Rovi Guides, Inc.,
`No. IPR2019-00231, Paper 44 (P.T.A.B. May 8, 2020),
`and that the ’011 patent was obvious over Gross and
`Smith, see Comcast Cable Commc’ns, LLC v. Rovi
`Guides, Inc., No. IPR2019-00239, Paper 50 (P.T.A.B.
`June 30, 2020).3
`This is not how the system is supposed to work.
`Patent owners should be entitled to some measure of
`repose. They should not be subjected to repeated
`attacks on the validity of their patents throughout
`their twenty-year term. The perpetual cloud of
`uncertainty that results from this system undermines
`the presumption of validity and harms incentives to
`innovate. It also flatly contradicts the original intent
`of the drafters of the AIA, who made clear that the
`new post-grant proceedings established by that
`statute were “not to be used as tools for harassment
`or a means to prevent market entry through repeated
`litigation and administrative attacks on the validity
`of a patent.” H.R. Rep. No. 112-98, pt. 1, at 48 (2011).
`2. TiVo, unfortunately, is not an outlier with
`regard to its experience with the inter partes review
`system. According to TiVo’s research, for patents that
`
`
`3 Rovi’s appeals of those decisions are currently pending
`before the Federal Circuit.
`
`
`
`

`

`9
`
`have survived a validity challenge in district court or
`the ITC and are also challenged before the Board, the
`Board institutes inter partes review at a rate of 58%
`and cancels claims upon which review was instituted
`at a rate of 63%.4 These numbers are only marginally
`lower than the corresponding rates for all challenged
`patents, which are 66% and 75%, respectively.5 In
`other words, patents that have survived an expensive
`validity challenge in district court or the ITC are
`almost as likely to be reviewed—and ultimately
`invalidated—by the Board as a patent that was never
`the subject of litigation. It is little wonder that
`accused infringers use inter partes reviews to gain a
`second bite at the invalidity apple.6
`3. This potential for abuse is further compounded
`by the Federal Circuit’s unworkable approach to
`preclusion in circumstances in which the same patent
`
`
`4 Patents with district-court or ITC determinations of non-
`invalidity were identified through a Docket Navigator search.
`PTAB outcomes for these patents were sourced from counsel’s
`compilation of PTAB proceedings and outcomes covering 2012–
`2020.
`5 This data likewise comes from counsel’s compilation of
`PTAB proceedings and outcomes covering 2012–2020.
`6 A separate but related problem arises when patent
`infringers file multiple petitions against a single patent at the
`same time (so-called “parallel petitions”). A recent analysis
`found that virtually any patent can be invalidated if enough
`parallel petitions are filed, regardless of the individual strength
`of each challenge viewed separately. See Matteo Sabatini, PTAB
`Challenges and Innovation: A Probabilistic Approach, SSRN
`https://papers.ssrn.com/
`(2020), available at
`3668216
`sol3/papers.cfm?abstract_id=3668216.
`
`
`

`

`10
`
`is challenged both in a district-court case and before
`the Board.
`Under the so-called Fresenius doctrine, if the same
`patent is at issue in both a district-court infringement
`case and a post-grant review proceeding, a finding of
`invalidity in the post-grant review proceeding will
`retroactively nullify any infringement and validity
`determinations by the district court if any part of the
`district-court proceeding remains ongoing when a
`finding of
`invalidity
`in the post-grant review
`proceeding is affirmed by an Article III court. See
`generally Fresenius USA, Inc. v. Baxter Int’l, Inc., 721
`F.3d 1330 (Fed. Cir. 2013).
`For example, in ePlus, Inc. v. Lawson Software,
`Inc., 760 F.3d 1350 (Fed. Cir. 2014), a district court
`issued an injunction after finding that Lawson had
`infringed five claims of ePlus’s patent. See id. at 1352.
`On appeal, the Federal Circuit affirmed the
`infringement verdict as to one claim (claim 26), found
`the other four claims either not infringed or invalid,
`and remanded to the district court to make any
`necessary modifications to the injunction. See id. On
`remand, the court modified the injunction to apply
`only to claim 26 and found Lawson in civil contempt
`for violating the injunction. Id. While the appeal from
`that finding was pending (and after the contemptible
`conduct occurred), the Federal Circuit in a separate
`case affirmed the Board’s finding that claim 26 was
`invalid. See id. Based on the latter judgment, the
`court of appeals vacated both the district court’s
`injunction and its contempt order. Id. The court of
`appeals also set aside the penalties imposed on
`Lawson for violating the injunction during the four
`
`
`

`

`11
`
`years it was in place before the Board’s cancellation
`of claim 26 was affirmed. See id. In short, a district-
`court
`judgment of
`infringement and validity—
`affirmed by the Federal Circuit—and subsequent
`findings of contempt were retroactively undone by an
`entirely separate administrative proceeding involving
`the patent.
`Unfortunately, ePlus is not an outlier. The Federal
`Circuit has applied Fresenius to, for example, vacate
`an already-affirmed infringement judgment (which
`provided a patentee with an ongoing royalty) based on
`a subsequent Board finding that the claims at issue
`were invalid. See Chrimar Sys., Inc. v. ALE USA Inc.,
`785 F. App’x 854, 856 (Fed. Cir. 2019); see also, e.g.,
`Hologic, Inc. v. Minerva Surgical, Inc., 957 F.3d 1256,
`1266 (Fed. Cir. 2020) (holding that, under Fresenius,
`an accused infringer may circumvent the assignor
`estoppel doctrine by challenging the patent in an inter
`partes review instead of in district court, and
`acknowledging the “unfairness” of this result); SHFL
`Entm’t, Inc. v. DigiDeal Corp., 729 F. App’x 931, 934
`(Fed. Cir. 2018) (applying Fresenius’s holding that
`“when a claim is cancelled, the patentee loses any
`cause of action based on that claim, and any pending
`litigation in which the claims are asserted becomes
`moot”) (quoting Fresenius, 721 F.3d at 1340); Target
`Training Int’l, Ltd. v. Extended Disc N. Am., Inc., 645
`F. App’x 1018, 1023 (Fed. Cir. 2016) (same).
`Several judges on the Federal Circuit have harshly
`criticized the Fresenius doctrine. This approach to
`preclusion, these judges have noted, “is at odds with
`all of the regional circuits,” which apply a “uniform
`rule . . . that a final judgment is final as to its subject
`
`
`

`

`12
`
`matter, even if other items remain for consideration
`or for remand.” ePlus, Inc. v. Lawson Software, Inc.,
`790 F.3d 1307, 1311 (Fed. Cir. 2015) (Newman, J.,
`joined by O’Malley and Wallach, JJ., dissenting from
`denial of rehearing en banc); see also id. (“There is no
`support in precedent for nullifying judicial rulings of
`infringement and injunction, retroactively, based on a
`subsequent decision of the Patent and Trademark
`Office.”).7
`Whatever one thinks of the Fresenius principle as
`a matter of doctrine, the rule indisputably creates the
`potential for parties adjudged of infringement in
`district court to undo that judgment via inter partes
`reviews. In effect, the rule permits the administrative
`patent judges to overrule the final judgments of
`Article III courts. See Fresenius USA, Inc. v. Baxter
`Int’l, Inc., 733 F.3d 1369, 1372 (Fed. Cir. 2013)
`(O’Malley, J., dissenting from denial of rehearing en
`banc) (Fresenius principle “goes a long way toward
`rendering district courts meaningless
`in
`the
`resolution of patent infringement disputes.”). And it
`“encourages defendants to scrap and fight to keep
`underlying litigation pending in the hope that they
`will fare better with the PTO and then be able to
`unravel the district court judgment against them.”
`ePlus, 790 F.3d at 1314 (Moore, J., joined by O’Malley,
`Reyna, and Wallach, JJ., dissenting from denial of
`rehearing en banc); see also Paul Gugliuzza, (In)valid
`Patents, 92 NOTRE DAME L. REV. 271, 308 (2016)
`
`
`7 Cf. Restatement (Second) of Judgments § 13, cmt. e (“A
`judgment may be final in a res judicata sense as to a part of an
`action although the litigation continues as to the rest.”).
`
`
`

`

`13
`
`(Fresenius principle “encourages wasteful procedural
`maneuvering” and “allows an adjudged infringer a
`second chance at proving
`invalidity”). It thus
`compounds the problems with the inter partes review
`regime identified above.
`
`B.
`
`The Board’s extraordinarily high claim-
`cancellation rates confirm that the inter
`partes review process is not a neutral
`alternative to adjudication of patent
`rights in federal court.
`
`1.
`
`Contrary to the suggestion of
`several amici, the Board’s claim-
`cancellation rates are much
`higher than those of district
`courts.
`
`Some amici supporting the United States and
`Smith & Nephew suggest that inter partes review is
`a neutral alternative to district court as a forum for
`litigating patentability because the Board invalidates
`claims at approximately the same rate as district
`courts. See, e.g., Br. of Cross-Industry Groups as
`Amicus Curiae in Support of Pet’rs at 6. But the
`premise of that argument is simply incorrect: the
`Board invalidates patent claims at a far higher rate
`than district courts do.
`Approximately 80% of all final written decisions
`result in the invalidation of at least some challenged
`claims, and over 60% result in the invalidation of all
`challenged claims. See https://www.uspto.gov/sites/
`default/files/documents/Trial_Statistics_20200630_.p
`df (slide 11). A recent analysis found that “84% of
`
`
`

`

`14
`
`patents that have been fully reviewed by the PTAB”
`have at least some claims invalidated. See Josh
`Malone, Assessing PTAB Invalidity Rates at 4,
`available at https://usinventor.org/assessing-ptab-
`invalidity-rates/ (Oct. 22, 2020). (The discrepancy
`between this figure and the 80% figure in the PTO
`statistics arises from the fact that some patents are
`the subject of multiple final written decisions.)
`Contrast these figures with outcomes in district
`courts, which confirm the validity of patents well over
`60% of the time.8 The takeaway is clear: the Board is
`a far less patent-friendly forum than Article III
`courts. (This is unsurprising given the differing
`standard of review in the two types of proceedings.
`Patent challengers in district court must prove
`invalidity by clear and convincing evidence, whereas
`challengers in inter partes reviews need only prove
`their case by a preponderance of the evidence. See
`Cuozzo Speed Techs., LLC v. Lee, 136 S. Ct. 2131,
`2144 (2016).) Thus, not only do inter partes reviews
`give patent infringers whose validity challenges have
`been unsuccessful in other fora a second bite at the
`invalidity apple; they give those infringers a second
`
`
`
`8 A 2014 law review article estimated that district courts
`confirm the validity of patents at a rate exceeding 60%. See John
`R. Allison et al., Understanding the Realities of Modern Patent
`Litigation, 92 TEX. L. REV. 1769, 1785 (2014). According to
`figures obtained from Docket Navigator regarding validity
`determinations at summary judgment and trial from 2014 to
`2020, district
`courts have
`confirmed patent validity
`approximately 63% of the time since 2014.
`
`
`

`

`15
`
`bite that is significantly more likely to succeed than
`the first.
`
`2.
`
`The high affirmance rate of
`Board decisions reflects the
`forgiving standard of review on
`appeal—not necessarily accuracy
`on the part of the Board.
`
`Various amici also point to the Federal Circuit’s
`high affirmance rate of Board decisions as evidence
`“that the Board is reaching appropriate decisions in
`post-grant review proceedings.” Br. of High Tech
`Inventors Alliance as Amicus Curiae in Support of
`Pet’rs at 17; see also, e.g., Br. of Amici Curiae
`Acushnet & Cleveland Golf in Support of Pet’rs at 14–
`18. This argument misunderstands the permissive
`standard of review that the Federal Circuit applies
`when reviewing Board decisions.
`Most patentability disputes turn on questions of
`fact: what the prior art discloses, whether a skilled
`artisan would have been motivated to combine
`different pieces of prior art to arrive at the claimed
`invention, etc. The Board’s factual determinations are
`reviewed for “substantial evidence,” meaning that the
`reviewing court asks “whether a reasonable mind
`might accept a particular evidentiary record as
`adequate to support a conclusion.” Dickinson v.
`Zurko, 527 U.S. 150, 162 (1999). In other words, when
`the Federal Circuit confronts appeals from inter
`partes review proceedings, it is asking not whether
`the Board’s conclusion was right, but instead whether
`it is supportable. See, e.g., Henkel Corp. v. Procter &
`Gamble Co., 560 F.3d 1286, 1290 (Fed. Cir. 2009)
`
`
`

`

`16
`
`(“The interpretation of the critical portion of the
`Metzger-Groom Report is a very close call, and can
`reasonably go either way. But our inquiry in this case
`is not how we would interpret this statement in the
`Metzger-Groom Report were we to do so in the first
`instance. Rather, our task is to determine whether
`the Board’s interpretation is supported by substantial
`evidence.”).9
`Even worse, the Federal Circuit does not even
`issue a written opinion in many appeals from Board
`decisions. Since the passage of the America Invents
`Act, the court of appeals has summarily affirmed
`approximately half of the appeals taken from Board
`decisions. See Rebecca Lindhorst, Because I Said So:
`The Federal Circuit, the PTAB, and the Problem with
`Rule 36 Affirmances, 69 CASE W. RES. L. REV. 247, 252
`(2018).10 Thus, in most cases in which the Federal
`Circuit concludes that the Board’s conclusions are
`supported by substantial evidence, it simply says so,
`
`
`9 As several Federal Circuit judges have observed, this
`permissive standard of review “makes little sense in th

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket